You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • 017 Preventing strokes from vasospasm and heparin induced thrombocytopenia type II: nicardipine, milrinone, angioplasty and Argtroban

Article Text

Article menu
Download PDFPDF
SNIS Annual Meeting oral abstracts
017 Preventing strokes from vasospasm and heparin induced thrombocytopenia type II: nicardipine, milrinone, angioplasty and Argtroban
  1. J Rabinov1,
  2. J Pryor2,
  3. R Nogueira1,
  4. A Yoo1,
  5. J Hirsch1
  1. 1Neuroradiology, Massachusetts General Hospital, Boston, Massachusetts, USA
  2. 2Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA

https://doi.org/10.1136/jnis.2009.000851q

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Purpose: To investigate the use of Argtroban in patients at risk for heparin induced thrombocytopenia type II (HIT) during intra-arterial (IA) therapy for subarachnoid hemorrhage (SAH) related vasospasm.

    Methods and Materials: In 2007, 33 patients underwent angiographic procedures for cerebral vasospasm following presentation to our institution with aneurysmal subarachnoid hemorrhage. 32 patients underwent pharmacologic IA therapy for SAH related vasospasm. The other patient underwent cerebral angiography and was treated with the Neuroflo aortic balloon catheter. The Neuroflo catheter was used in two patients, one as adjunctive therapy and one as the sole mode of therapy. 10 men and 23 women …

    View Full Text